ArticleTranslational lung cancer research2023

Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.

Jun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.